Anja Oštrbenk Valenčak

Methylation markers <scp><i>FAM19A4</i></scp> and <i><scp>miR124</scp>‐2</i> as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

Jesper Bonde, Arno Floore, Ditte Møller Ejegod et al. · International Journal of Cancer · 2020 · 113 citations · Full text

Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample

Polona Maver Vodičar, Anja Oštrbenk Valenčak, Blaž Zupan et al. · Clinical Microbiology and Infection · 2020 · 46 citations · Full text

Epidemiological Trend, Covid-19 Pandemic, Probability-based Sample +9

Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain

Mario Poljak, Anja Oštrbenk Valenčak, Tina Štamol et al. · Journal of Clinical Virology · 2021 · 40 citations · Full text

Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings

Anja Oštrbenk Valenčak, Anja Šterbenc, Katja Seme et al. · Journal of Clinical Microbiology · 2019 · 25 citations · Full text

<i>FAM19A4/miR124-2</i> Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years

Frederique J. Vink, Chris J.L.M. Meijer, Albertus T. Hesselink et al. · Clinical Infectious Diseases · 2022 · 25 citations · Full text